Influence of TNF-α blockers on the oral prevalence of opportunistic microorganisms in ankylosing spondylitis patients

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 679-685

  Pereira, D F A ^a   Pinheiro, M M ^b   Silva, P N F ^a   Teodoro, G R ^a   Brighenti, F L ^a   Koga Ito, C Y ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ankylosing spondylitis; Candida; Infection; Oral microbiology; Staphylococcus; Super infection; TNF blockers

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CARBAPENEM; CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE; METHOTREXATE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALAZOSULFAPYRIDINE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE DURATION; ENTEROBACTERIACEAE; FEMALE; HUMAN; INFECTION RISK; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; SALIVATION; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUPERINFECTION;

ADULT; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BRAZIL; CHI-SQUARE DISTRIBUTION; COLONY COUNT, MICROBIAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOUTH; MOUTH DISEASES; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870274113     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. MUNDWILER ML, MEI L, LANDERS CJ, REVEILLE JD, TARGAN S, WEISMAN MH: Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthritis Res Titer 2009;11:177.
2. SHAMJI MF, BAFAQUH M, TSAI E: The pathogenesis of ankylosing spondylitis. Neurosurg Focus 2008;24:E3.
3. BARKHUIZEN A, STEINFELD S, ROBBINS J, WEST C, COOMBS J, ZWILLICH S: Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis. J Rheumatol 2006;33:1805-12.
4. BERNATSKY S, HUDSON M, SUISSA S: Antirheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 2007;46:1157-60.
5. CECON F, FERREIRA LE, ROSA RT et al:. Time-related increase of staphylococci, Enterobacteriaceae and yeasts in the oral cavities of comatose patients. J Microbiol Immunol Infect 2010;43:457-63.
6. PARAHITIYAWA NB, JIN U, LEUNG WK, YAM WC, SAMARANAYAKE LP: Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev 2009;22:46-64.
7. GONÇALVES MO, COUTINHO-FILHO WP, PIMENTA FP et al.: Periodontal disease as reservoir for multi-resistant and hydrolytic enterobacterial species. Lett Appl Microbiol 2007;44:488-94.
8. WERTHEIM HF, MELLES DC, VOS MC et al.: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62.
9. WATAMOTO T, SAMARANAYAKE LP, JAYATILAKE JAMS, EGUSA H, YATANI H, SENEVIRATNE CJ: Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Int J Antimicrob Agents 2009;34:333-9.
10. CHEN SC, MARRIOTT D, PLAYFORD EG et al.; AUSTRALIAN CANDIDAEMIA STUDY: Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009;15:662-9.
11. VAN der LINDEN S, VALKENBURG HA, CATS A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
12. KRASSE B: Interpretation and use of microbiological findings in dental caries. Oral Microbiol Immunol 1986;1:85-6.
13. GARRETT S, JENKINSON T, KENNEDY LG, WHITELOCK H, GAISFORD P, CALIN A: A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
14. NCCLS: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. In NCCLS document M27-A2 [ISBN 1-56238-469-4]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pensylvania 19087-1898 USA, 2002).
15. SUTTON PA, FOTHERGILL AM, RINALDI MG: Clinically significant fungi. Baltimore: William & Wilkins; 1998.
16. CLSI (CLINICAL AND LABORATORY STANDARDS INSTITUTE)/NCCLS: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, Sixth edition. NCCLS document M7-A6, NCCLS, 2003.
17. GARCIA-CORTÉ S, MEDINA-SOLIS CE, LOYOLA-RODRIGUEZ JP et al.: Dental caries experience, prevalence and severity in mexican adolescents and young adults. Rev Salud Publico 2009;11:82-91.
18. SAMARANAYAKE LP, MACFARLANE TW, LAMEY PJ, FERGUSON MM: A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986;15:386-8.
19. THAWEBOON S, THAWEBOON B, SRITHAVAJ T, CHOONHARUANGDEJ S: Oral colonization of Candida species in patients receiving radiotherapy in the head and neck area. Quintessence Int 2008;39:52-7.
20. BACK-BRITO GN, ELACKHAR VN, QUERIDO SM et al.: Staphylococcus spp., Enterobacteriaceae and Pseudomonadaceae oral isolates from Brazilian HIV-positive patients. Correlation with CD4 cell counts and viral load. Arch Oral Biol 2011;56:1041-6.
21. RIBEIRO PM, BACAL F, KOGA-ITO CY, JUNQUEIRA JC, JORGE AO: Presence of Candida spp. in the oral cavity of heart transplantation patients. J Appl Oral Sci 2011;19:6-10.
22. OLCZAK-KOWALCZYK D, PAWłOWSKA J, CUKROWSKA B et al:. Local presence of cytomegalovirus and Candida species vs oral lesions in liver and kidney transplant recipients. Ann Transplant 2008;13:28-33.
23. DE ARAÚJO NAVAS EA, INOCÊNCIO AC, ALMEIDA JD et al:. Oral distribution of Candida species and presence of oral lesions in Brazilian leprosy patients under multidrug therapy. J Oral Pathol Med 2009;38:764-7.
24. DARWAZEH AM, HAMMAD MM, AL-JAMAEI AA: The relationship between oral hygiene and oral colonization with Candida species in healthy adult subjects. Int J Dent Hyg 2010;8:128-33.
25. EGGIMANN P, GARBINO J, PITTET D: Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003;3:772-85.
26. AL-ABEID HM, ABU-ELTEEN KH, ELKARMI AZ, HAMAD MA: Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis 2004;57:279-84.
27. LAUPLAND KB, GREGSON DB, CHURCH DL, ROSS T, ELSAYED S: Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother 2005;56:532-7.
28. BACK-BRITO GN, MOTA AJ, VASCONCELLOS TC et al:. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia 2009;167:81-7.
29. BASSETTI S, WASMER S, HASLER P et al:. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 2005;32:2125-9.
30. ROOS JC, OSTOR AJ: Orbital cellulitis in a patient receiving infliximab for Ankylosing spondylitis. Am J Ophthalmol 2006;141:767-9.
31. SCHMIDT-WESTHAUSEN A, SCHILLER RA, POHLE HD, REICHART PA: Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy. J Oral Pathol Med 1991;20:467-72.
32. COWLING P, EBRINGER R, CAWDELL D, ISHII M, EBRINGER A: C-reactive protein, ESR, and Klebsiella in ankylosing spondylitis. Ann Rheum Dis 1980;39:45-9.
33. EBRINGER A, RASHID T, TIWANA H, WILSON C: A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clin Rheumatol 2007;26:289-97.
34. RASHID T, EBRINGER A, WILSON C, BANSAL S, PAIMELA L, BINDER A: The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis. J Clin Rheumatol 2006;12:11-6.
35. MARTÍNEZ A, PACHECO-TENA C, VÁZQUEZMELLADO J, BURGOS-VARGAS R: Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis 2004;63:1338-40.
36. RASHID T, EBRINGER A: Ankylosing spondylitis is linked to Klebsiella-the evidence. Clin Rheumatol 2007;26:858-64.
37. SILVA AP, MIRANDA IM, LISBOA C, PINA-VAZ C, RODRIGUES AG: Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J Clin Microbiol 2009;47:2392-7.
38. DE CARVALHO MJ, PIMENTA FC, HAYASHIDA M et al:. Prevalence of methicillin-resistant and methicillin-susceptible S. aureus in the saliva of health professionals. Clinics 2009;64:295-302.